Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-02-01
2005-02-01
Winkler, Ulrike (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C435S069100, C435S235100, C536S023720
Reexamination Certificate
active
06849261
ABSTRACT:
The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.
REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 5614612 (1997-03-01), Haigwood et al.
Ngo et al., Computational complexity, protein structure prediction and the levinthal paradox, In: The Protein Folding Problem and Tertiary Structure Prediction, Edited: Mertz and LeGrand (1994) pp. 492-495.*
Bork P., Powers and Pitfalls in sequence analysis the 70% hurdle, Genome Research (2000) vol. 10, pp. 398-400.*
Sergel et al. A Single amino acid change in Newcastle disease virus fusion protein alters the requirements for HN protein in fusion, Journal of Virology (2000) pp. 5101-5107).*
Alexander et al., 1992, 1992, J. Virol. 66:2934-2942.
Alkhatib et al., 1996, Science 272:1955-1958.
Bandres et al., 1998, J. Virol. 72:2500-2504.
Berger, 1997, AIDS 11:S3-S16.
Bird et al., 1988, Science 242:423-426.
Burger et al., 1991, J. Gen. Virol. 72:359-367.
Burton and Motefiori, 1997, AIDS 11 (Supp. A):S87-S98.
Cao et al., 1993, J. Virol. 67:2747-2755.
Cao et al., 1997, J. Virol. 71:9808-9812.
Chackerian et al., 1997, J. Virol. 71:3932-3939.
Chan et al., 1997, Cell 89:263-273.
Chen et al.,1996, Virology 226:260-268.
Cho et al., 1998, J. Virol. 72:2509-2515.
Choe et al., 1996, Cell 85:1135-1148.
Cocchi et al., 1996, Nature Med. 2:1244-1247.
Connor et al., 1995, Virology 206:935-944.
Connor et al., 1997, J. Exp. Med. 185:621-628.
Cranage et al., 1986, EMBO J. 5:3057-3063.
Deng et al.,1996, Nature 381:661-666.
Deng et al., 1997, Nature 388:296-300.
Doranz et al., 1996, Cell 85:1149-1158.
Doranz et al., 1999, J. Virol., 73:2752-2761.
Doranz et al., 1997, J. Exp. med. 186:1395-1400.
Dragic et al., 1996, Nature 381:667-673.
Dubay et al., 1992, J. Virol. 66:6616-6625.
Dumonceaux et al., 1998, J. Virol. 72:512-519.
Earl et al., 1997, J. Virol. 71:2674-2684.
Edinger et al., 1997, Proc. Natl. Acad. Sci. USA 94:14742-14747.
Endres et al., 1996, Cell 87:745-756.
Endres et al., 1997, Science 278:1462-1464.
Farzan et al., 1997, J. Exp. Med. 186:405-411.
Feng et al., 1996, Science 272:872-876.
Gibbs et al., 1994, AIDS Res. Hum. Retroviruses. 10:343-350.
Haigwood et al., 1992, J. Med. Primatol. 21:82-90.
Hesselgesser et al., 1997, Curr. Biol. 7:112-121.
Hill et al., 1997, J. Virol. 71:6296-6304.
Hoffman et al., 1998, Proc. Natl. Acad. Sci. U.S.A. 95:11360-11365.
Hoffman and Doms, 1998, AIDS 12:S17-S26.
Huston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883.
Hoxie et al., 1985, Science 229:1400-1402.
Hwang et al., 1991, Science 253:71-74.
Jones et al., 1998, J. Biol. Chem. 273:404-409.
Kay et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:12744-12746.
Kielian, 1995, Advances in Virus Res. 45:113-151.
Kilby et al., 1998, Nature Med. 4:1302-1307.
Kozak et al., 1997, J. Virol. 71:873-882.
Kwong et al., 1998, Nature 393:648-659.
LaBranche et al., 1995, J. Virol. 69:5217-5227.
LaCasse et al., 1999, Science 283:357-362.
Lapham et al., 1996, Science 274:602-605.
Lee et al., 1999, J. Biol. Chem., 274:9617-9616.
Liao et al., 1997, J. Exp. Med. 185:2015-2023.
Martin et al., 1997, Science 278:1470-1473.
Matthews et al., 1994, Immunol. Rev. 140:93-104.
Misse et al., 1998, J. Virol. 72:7280-7288.
Moore and Ho, 1995, AIDS 9:S117-S136.
Moore et al., 1994, J. Virol. 68:469-484.
Mulligan et al., 1992, J. Virol. 66:3971-3975.
Olshevsky et al., 1990, J. Virol. 64:5701-5705.
Olson et al., 1999, J. Virol., in press.
Perelson et al., 1996, Science 271:1582-1586.
Platt et al., 1998, J. Virol. 72:2855-2864.
Pollard and Malim, 1998, Annu. Rev. Microbiol. 52:491-532.
Popovic et al., 1984, Science 224:497-500.
Reeves et al., 1996, J. Virol. 71:1453-1465.
Reeves and Schulz, 1996, J. Virol. 71:1453-1465.
Reitter et al., 1998, Nature Med. 4:679-684.
Ritter et al., 1993, Virology 197:255-264.
Rizzuto et al., 1998, Science 280:1949-1953.
Ross and Cullen, 1998, Proc. Natl. Acad. Sci. U.S.A. 95:7682-7686.
Ross et al., 1997, J. Virol. 72:1918-1924.
Ross et al. 1998, Proc. Natl. Acad. Sci. U.S.A. 95:7682-7686.
Rucker et al., 1997, Methods Enzymol. 288:118-133.
Rucker et al., 1997, J. Virol. 71:8999-9007.
Shimizu et al., 1992, Virology 189:534-546.
Speck et al., 1997, J. Virol. 71:7136-7139.
Spies et al., 1994, J. Virol. 68:585-591.
Stamatatos and Cheng-Mayer, 1998, J. Virol. 72:7840-7845.
Thali et al., 1993, J. Virol. 67:3978-3988.
Trkola et al., 1996, Nature 384:184-187.
Trkola et al., 1998, J. Virol. 72:1876-1885.
Wei et al., 1995, Nature 373:117-122.
Wu et al., 1996, Nature 384:179-183.
Wu et al., 1997, J. Exp. Med.
Wyatt et al., 1998, Nature 393:705-710.
Wyatt et al., 1995, J. Virol. 66:5723-5733.
Wyatt et al., 1992, J. Virol. 66:6997-7004.
Wyatt and Sodroski, 1998, Science 280:1884-1888.
Zhang et al., 1998, J Virol. 72:9337-9344.
LaBranche, C.C., “Human Immunodeficiency Virus Type 1”, (Jan. 17, 2000), EMBL Database Accession No. AF189159.
Doms Robert W.
Hoffman Trevor L.
Hoxie James A.
LaBranche Celia C.
Morgan & Lewis & Bockius, LLP
The Trustees of the University of Pennsylvania
Winkler Ulrike
LandOfFree
CD4-independent HIV envelope proteins as vaccines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CD4-independent HIV envelope proteins as vaccines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD4-independent HIV envelope proteins as vaccines and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3486670